Condition
Diuretics Drug Reactions
Total Trials
6
Recruiting
2
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (2)
Trial Status
Completed3
Recruiting2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04676399Early Phase 1Active Not Recruiting
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
NCT05411991Phase 4Completed
Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
NCT04934228Phase 1Recruiting
Mitigating the Pro-inflammatory Phenotype of Obesity
NCT06630923Phase 3RecruitingPrimary
PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS
NCT05904808Phase 4Completed
The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study
NCT04740242Completed
Metabolic Alkalosis in Heart Failure
Showing all 6 trials